TL
TEVA icon

Tirschwell & Loewy’s Teva Pharmaceuticals TEVA Stock Holding History

Tirschwell & Loewy’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-7,300
Closed -$293K – 83
2013
Q4 		$293K Sell
7,300
-6,800
-48% -$268K 0.05% 74
2013
Q3 		$533K Sell
14,100
-7,150
-34% -$279K 0.1% 70
2013
Q2 		$833K Buy
+21,250
New +$828K 0.18% 66

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
SFM
Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

Tirschwell & Loewy's TEVA Position: Q1 2014 in Review

Tirschwell & Loewy sold out of Teva Pharmaceuticals (TEVA) in Q1 2014, closing a stake of 7,300 shares — an estimated $293K sold.

Tirschwell & Loewy first reported a position in TEVA in Q2 2013 and held it in 3 quarters. The position peaked at $833K in Q2 2013. 770 funds tracked by Wall St. Rank hold TEVA as of Q1 2014.

  • Tirschwell & Loewy reported no remaining Teva Pharmaceuticals position as of Q1 2014 after selling out during the quarter.
  • Tirschwell & Loewy sold 7,300 Teva Pharmaceuticals shares in Q1 2014, an estimated $293K.
  • Tirschwell & Loewy first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 3 quarters.
  • Tirschwell & Loewy's Teva Pharmaceuticals position peaked at $833K in Q2 2013.
  • 770 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2014.

Based on Tirschwell & Loewy's 13F filing for Q1 2014, filed 1 May 2014.